Wound healing and local neuroendocrine regulation in the injured liver

Mohammad R. Ebrahimkhani; Ahmed M. Elsharkawy; Derek A. Mann

doi:10.1017/S146239940800063X

Wound healing and local neuroendocrine regulation in the injured liver

Published online by Cambridge University Press: 29 April 2008

Mohammad R. Ebrahimkhani ,

Ahmed M. Elsharkawy and

Derek A. Mann

Show author details

Mohammad R. Ebrahimkhani: Affiliation:
Cell signalling, Liver Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
Ahmed M. Elsharkawy: Affiliation:
Cell signalling, Liver Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
Derek A. Mann*: Affiliation:
Cell signalling, Liver Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
*: *Corresponding author: Prof. Derek A. Mann, Liver Group, Institute of Cellular Medicine, 4th Floor, Cookson Building, Medical School, University of Newcastle, Newcastle upon Tyne, NE2 4HH, UK. Tel: +44 191 2223851; Fax: +44 191 2225455; E-mail: [email protected]

Article contents

Abstract
References

Get access

Rights & Permissions

Abstract

The hepatic wound-healing response is a complex process involving many different cell types and factors. It leads to the formation of excessive matrix and a fibrotic scar, which ultimately disrupts proper functioning of the liver and establishes cirrhosis. Activated hepatic myofibroblasts, which are derived from cells such as hepatic stellate cells (HSCs), play a key role in this process. Upon chronic liver injury, there is an upregulation in the local neuroendocrine system and it has recently been demonstrated that activated HSCs express specific receptors and respond to different components of this system. Neuroendocrine factors and their receptors participate in a complex network that modulates liver inflammation and wound healing, and controls the development and progression of liver fibrosis. The first part of this review provides an overview of the molecular mechanisms governing hepatic wound healing. In the second section, we explore important components of the hepatic neuroendocrine system and their recently highlighted roles in HSC biology and hepatic fibrogenesis. We discuss the therapeutic interventions that are being developed for use in antifibrotic therapy.

Type: Review Article
Information: Expert Reviews in Molecular Medicine , Volume 10 , October 2008 , e11

DOI: https://doi.org/10.1017/S146239940800063X [Opens in a new window]
Copyright: Copyright © Cambridge University Press 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Racanelli, V. and Rehermann, B. (2006) The liver as an immunological organ. Hepatology 43 (Suppl 1), S54-S62CrossRef Google Scholar PubMed

2Friedman, S.L. (2000) Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275, 2247-2250CrossRef Google Scholar PubMed

3Novo, E. et al. (2007) Proangiogenic Cytokines as Hypoxia-Dependent Factors Stimulating Migration of Human Hepatic Stellate Cells. Am J Pathol 170, 1942-1953CrossRef Google Scholar PubMed

4Ramadori, G. et al. (1992) The gene of hepatocyte growth factor is expressed in fat-storing cells of rat liver and is down regulated during cell growth and by transforming growth factor-beta. Biochem Biophys Res Commun 183, 739-742CrossRef Google Scholar PubMed

5Xu, J. et al. (2007) Characterization of a Putative Intrarenal Serotonergic System. Am J Physiol Renal Physiol 293, 1468-1475CrossRef Google Scholar PubMed

6Bigliardi-Qi, M. et al. (2006) Deletion of delta-opioid receptor in mice alters skin differentiation and delays wound healing. Differentiation 74, 174-185CrossRef Google Scholar PubMed

7Kawamoto, K. and Matsuda, H. (2004) Nerve growth factor and wound healing. Prog Brain Res 146, 369-384CrossRef Google Scholar PubMed

8Wynn, T.A. (2007) Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 117, 524-529CrossRef Google Scholar PubMed

9Desmouliere, A., Chaponnier, C. and Gabbiani, G. (2005) Tissue repair, contraction, and the myofibroblast. Wound Repair Regen 13, 7-12CrossRef Google Scholar PubMed

10Meneghin, A. and Hogaboam, C.M. (2007) Infectious disease, the innate immune response, and fibrosis. J Clin Invest 117, 530-538CrossRef Google Scholar PubMed

11Adzick, N.S. et al. (1985) Comparison of fetal, newborn, and adult wound healing by histologic, enzyme-histochemical, and hydroxyproline determinations. J Pediatr Surg 20, 315-319CrossRef Google Scholar PubMed

12Stramer, B.M., Mori, R. and Martin, P. (2007) The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair. J Invest Dermatol 127, 1009-1017CrossRef Google Scholar

13Kumagai, K. et al. (1999) Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma. J Immunol 162, 4212-4219CrossRef Google Scholar

14Iredale, J.P. (2007) Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 117, 539-548CrossRef Google Scholar

15McCawley, L.J. and Martrisian, L.M. (2001) Matrix metalloproteinases: they're not just for matrix anymore. Curr Opin Cell Biol 13, 534-540CrossRef Google Scholar

16Elsharkawy, A.M., Oakley, F., Mann, D.A. (2005) The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis 10, 927-939CrossRef Google Scholar PubMed

17Mutsaers, S.E. et al. (1997) Mechanisms of tissue repair: from wound healing to fibrosis. Int J Biochem Cell Biol 29, 5-17CrossRef Google Scholar PubMed

18Parsonage, G. et al. (2005) A stromal address code defined by fibroblasts. Trends Immunol 26, 150-156CrossRef Google Scholar PubMed

19Sempowski, G.D. et al. (1995) Fibroblasts heterogeneity in the healing wound. Wound Repair Regen 3, 120-131CrossRef Google Scholar PubMed

20Forbes, S.J. et al. (2004) A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 126, 955-963CrossRef Google Scholar PubMed

21Russo, F.P. et al. (2006) The bone marrow functionally contributes to liver fibrosis. Gastroenterology 130, 1807-1821CrossRef Google Scholar PubMed

22Kisseleva, T. et al. (2006) Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol 45, 429-438CrossRef Google Scholar PubMed

23Kinnman, N. and Housset, C. (2002) Peribiliary myofibroblasts in biliary type liver fibrosis. Front Biosci 7, 496-503CrossRef Google Scholar PubMed

24Knittel, T. et al. (1999) Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential. Gastroenterology 117, 1205-1221CrossRef Google Scholar PubMed

25Zeisberg, M. et al. (2007) Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 282, 23337-23347CrossRef Google Scholar PubMed

26Diaz, R. et al. (2008) Evidence for the epithelial to mesenchymal transition in biliary atresia fibrosis. Hum Pathol 39, 102-115CrossRef Google Scholar PubMed

27Robertson, H. et al. (2007) Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis. Hepatology 45, 977-981CrossRef Google Scholar PubMed

28Kaimori, A. et al. (2007) Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J Biol Chem 282, 22089-22101CrossRef Google Scholar

29Tuchweber, B. et al. (1996) Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat. Lab Invest 74, 265-278Google Scholar PubMed

30Tang, L. at al. (1994) Phenotypic change in portal fibroblasts in biliary fibrosis. Liver 14, 76-82CrossRef Google Scholar PubMed

31Chi, H. and Flavell, R.A. (2007) Immunology: sensing the enemy within. Nature 448, 423-424CrossRef Google Scholar

32Canbay, A., Friedman, S. and Gores, G.J. (2004) Apoptosis: the nexus of liver injury and fibrosis. Hepatology 39, 273-278CrossRef Google Scholar PubMed

33Watanabe, A. et al. (2007) Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9. Hepatology 46, 1509-1518CrossRef Google Scholar PubMed

34Maher, J. J. (1999) Leukocytes as modulators of stellate cell activation. Alcohol Clin Exp Res 23, 917-921CrossRef Google Scholar PubMed

35Urtasun, R. and Nieto, N. (2007) Hepatic stellate cells and oxidative stress. Rev Esp Enferm Dig 99, 223-230Google Scholar PubMed

36Georges, P.C. et al. (2007) Increased Stiffness of the Rat Liver Precedes Matrix Deposition: Implications for Fibrosis. Am J Physiol Gastrointest Liver Physiol 293, 1147-1154CrossRef Google Scholar PubMed

37Paik, Y.H. et al. (2003) Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 37, 1043-1055CrossRef Google Scholar PubMed

38Canbay, A. et al. (2004) The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse. J Pharmacol Exp Ther 308, 1191-1196CrossRef Google Scholar PubMed

39Canbay, A. et al. (2003) Apoptotic body engulfment by a human stellate cell line is profibrogenic. Lab Invest 83, 655-663CrossRef Google Scholar PubMed

40Seki, E. et al. (2007) TLR4 enhances TGF-b signalling and hepatic fibrosis. Nat Med 13, 1324-1332CrossRef Google Scholar PubMed

41Winau, F. et al. (2007) Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 26, 117-129CrossRef Google Scholar PubMed

42Thurman, R. G. (1998) Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am J Physiol 275, G605-G611Google Scholar PubMed

43Liu, C. et al. (2003) Smads 2 and 3 are differentially activated by transforming growth factor-beta (TGF-beta) in quiescent and activated hepatic stellate cells. Constitutive nuclear localization of Smads in activated cells is TGF-beta-independent. J Biol Chem 278, 11721-11728CrossRef Google Scholar PubMed

44Meyer, D.H., Bachem, M.G. and Gressner, A.M. (1990) Transformed fat storing cells inhibit the proliferation of cultured hepatocytes by secretion of transforming growth factor beta. J Hepatol 11, 86-91CrossRef Google Scholar PubMed

45Bataller, R. et al. (2003) NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest 112, 1383-1394CrossRef Google Scholar PubMed

46Bataller, R. et al. (2000) Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology 118, 1149-1156CrossRef Google Scholar PubMed

47Pinzani, M. et al. (1995) Transforming growth factor-beta 1 regulates platelet-derived growth factor receptor beta subunit in human liver fat-storing cells. Hepatology 21, 232-239Google Scholar PubMed

48Sprenger, H. et al. (1999) Differential expression of monocyte chemotactic protein-1 (MCP-1) in transforming rat hepatic stellate cells. J Hepatol 30, 88-94CrossRef Google Scholar PubMed

49Marra, F. et al. (1999) Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. Hepatology 29, 140-148CrossRef Google Scholar PubMed

50Ankoma-Sey, V. et al. (1998) Coordinated induction of VEGF receptors in mesenchymal cell types during rat hepatic wound healing. Oncogene 17, 115-121CrossRef Google Scholar PubMed

51Nieto, N. (2006) Oxidative-stress and IL-6 mediate the fibrogenic effects of Kupffer cells on stellate cells. Hepatology 44, 1487-1501CrossRef Google Scholar PubMed

52Murphy, F.R. et al. (2002) Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis. J Biol Chem 277, 11069-11076CrossRef Google Scholar PubMed

53Zhou, X. et al. (2004) Engagement of alphavbeta3 integrin regulates proliferation and apoptosis of hepatic stellate cells. J Biol Chem 279, 23996-24006CrossRef Google Scholar PubMed

54Benyon, R.C. and Arthur, M.J. (2001) Extracellular matrix degradation and the role of hepatic stellate cells. Semin Liver Dis 21, 373-384CrossRef Google Scholar PubMed

55Alvaro, D. et al. (2007) Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. Gastroenterology 132, 415-431CrossRef Google Scholar PubMed

56Roskams, T. et al. (2004) Neuroregulation of the neuroendocrine compartment of the liver. Anat Rec A Discov Mol Cell Evol Biol 280, 910-923CrossRef Google Scholar PubMed

57Roskams, T . et al. (1990) Neuroendocrine features of reactive bile ductules in cholestatic liver disease. Am J Pathol 137, 1019-1025Google Scholar PubMed

58Roskams, T. and Desmet, V. (1997) Parathyroid-hormone-related peptides: a new class of multifunctional proteins. Am J Pathol 150, 779-785Google Scholar PubMed

59Marzioni, M. et al. (2005) Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin. Gastroenterology 128, 121-137CrossRef Google Scholar PubMed

60Mosca, A. et al. (2004) Somatostatin receptors: from basic science to clinical approach. Unlabeled somatostatin analogues-1: Prostate cancer. Dig Liver Dis (Suppl 1) 36, S60-S67CrossRef Google Scholar PubMed

61Marzioni, M., Fava, G. and Benedetti, A. (2006) Nervous and neuroendocrine regulation of the pathophysiology of cholestasis and of biliary carcinogenesis. World J Gastroenterol 12, 3471-3480CrossRef Google Scholar PubMed

62Bosman, F.T. (1997) Neuroendocrine cells in non-endocrine tumors: what does it mean? Verh Dtsch Ges Pathol 81, 62-72Google Scholar PubMed

63di Sant'Agnese, P.A. and Cockett, A.T. (1996) Neuroendocrine differentiation in prostatic malignancy. Cancer 78, 357-3613.0.CO;2-U>CrossRef Google Scholar PubMed

64Amorino, G.P. and Parsons, S.J. (2004) Neuroendocrine cells in prostate cancer. Crit Rev Eukaryot Gene Expr 14, 287-300CrossRef Google Scholar PubMed

65Walker, G.E. et al. (2006) Neuroendocrine-like differentiation of non-small cell lung carcinoma cells: regulation by cAMP and the interaction of mac25/IGFBP-rP1 and 25.1. Oncogene 25, 1943-1954CrossRef Google Scholar PubMed

66Nesland, J.M. et al. (1988) Neuroendocrine differentiation in breast lesions. Pathol Res Pract 183, 214-221CrossRef Google Scholar PubMed

67Eren, F., Celikel, C. and Güllüoğlu, B. (2004) Neuroendocrine differentiation in gastric adenocarcinomas; correlation with tumor stage and expression of VEGF and p53. Pathol Oncol Res 10, 47-51CrossRef Google Scholar PubMed

68Atasoy, P. et al. (2003) Neuroendocrine differentiation in colorectal carcinomas: assessing its prognostic significance. Tumori 89, 49-53CrossRef Google Scholar PubMed

69DeMorrow, S. et al. (2007) Opposing actions of endocannabinoids on cholangiocarcinoma growth: recruitment of Fas and Fas ligand to lipid rafts. J Biol Chem 282, 13098-13113CrossRef Google Scholar PubMed

70Chang, K.T. et al. (2005) Role of IL-6 in neuroendocrine differentiation and chemosensitivity of non-small cell lung cancer. Am J Physiol Lung Cell Mol Physiol 289, L438-445Google Scholar PubMed

71Dvorak, H.F. (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315, 1650-1659Google Scholar

72Lin, W.W. and Karin, M. (2007) A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117, 1175-1183CrossRef Google Scholar PubMed

73Elsharkawy, A.M. and Mann, D.A. (2007) Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis. Hepatology 46, 590-597CrossRef Google Scholar PubMed

74Ruddell, R.G. et al. (2006) A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis. Am J Pathol 169, 861-876CrossRef Google Scholar PubMed

75Ebrahimkhani, M.R. et al. (2006) Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats. Gut 55, 1606-1616CrossRef Google Scholar PubMed

76Yang, Y.Y. et al. (2007) Effect of chronic CB1 cannabinoid receptor antagonism on livers of rats with biliary cirrhosis. Clin Sci (Lond) 112, 533-542CrossRef Google Scholar PubMed

77Micera, A. et al. The pro-fibrogenic effect of nerve growth factor on conjunctival fibroblasts is mediated by transforming growth factor-beta. Clin Exp Allergy 35, 650-656CrossRef Google Scholar

78Libbrecht, L. and Roskams, T. (2002) Hepatic progenitor cells in human liver diseases. Semin Cell Dev Biol 13, 389-396CrossRef Google Scholar PubMed

79Roskams, T. et al. (1991) Cells with neuroendocrine features in regenerating human liver. APMIS 23, 32-39Google Scholar PubMed

80Geerts, A. (2001) History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin Liver Dis 21, 311-335CrossRef Google Scholar PubMed

81Cassiman, D. et al. (1999) Synaptophysin: A novel marker for human and rat hepatic stellate cells. Am J Pathol 155, 1831-1839CrossRef Google Scholar PubMed

82Schurmann, G. et al. (1990) Chromogranin A, neuron-specific enolase and synaptophysin as neuroendocrine cell markers in the diagnosis of tumours of the gastro-entero-pancreatic system. Eur J Surg Oncol 16, 298-303Google Scholar PubMed

83Cassiman, D. et al. (2001) Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors. Hepatology 33, 148-158CrossRef Google Scholar PubMed

84Haley, K.J. et al. (1998) Tumor necrosis factor induces neuroendocrine differentiation in small cell lung cancer cell lines. Am J Physiol 275, L311-321Google Scholar PubMed

85Alvaro, D., Gigliozzi, A. and Attili, A.F. (2000) Regulation and deregulation of cholangiocyte proliferation. J Hepatol 33, 333-340CrossRef Google Scholar PubMed

86Lazaridis, K.N., Strazzabosco, M. and LaRusso, N.F. (2004) The cholangiopathies: disorders of biliary epithelia. Gastroenterology 127, 1565-1577CrossRef Google Scholar PubMed

87Qiu, Y., Ravi, L. and Kung, H.J. (1998) Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells. Nature 393, 83-85CrossRef Google Scholar PubMed

88Qiu, Y. et al. (1998) Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3′-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells. Proc Natl Acad Sci U S A 95, 3644-3649CrossRef Google Scholar PubMed

89Gigliozzi, A. et al. (2004) Nerve growth factor modulates the proliferative capacity of the intrahepatic biliary epithelium in experimental cholestasis. Gastroenterology 127, 1198-1209CrossRef Google Scholar PubMed

90Oakley, F. et al. (2003) Hepatocytes express nerve growth factor during liver injury: evidence for paracrine regulation of hepatic stellate cell apoptosis. Am J Pathol 163, 1849-1858CrossRef Google Scholar PubMed

91Passino, M.A. et al. (2007) Regulation of hepatic stellate cell differentiation by the neurotrophin receptor p75NTR. Science 315, 1853–1856CrossRef Google Scholar PubMed

92Micera, A. et al. (2001) Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proc Natl Acad Sci U S A 98, 6162-6167CrossRef Google Scholar PubMed

93Micera, A. et al. (2007) Nerve growth factor and tissue repair remodeling: trkA(NGFR) and p75(NTR), two receptors one fate. Cytokine Growth Factor Rev 18, 245-256CrossRef Google Scholar PubMed

94Gershon, M.D. and Tack, J. (2007) The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 132, 397-414CrossRef Google Scholar PubMed

95Lesurtel, M. et al. (2006) Platelet-derived serotonin mediates liver regeneration. Science 312, 104-107CrossRef Google Scholar PubMed

96Li, T. et al. (2006) Effects of 5-hydroxytamine and its antagonists on hepatic stellate cells. Hepatobiliary Pancreat Dis Int 5, 96-100Google Scholar PubMed

97Mani, A.R. et al. (2006) Endogenous opioids and liver disease. Scand J Gastroenterol 41, 1-11CrossRef Google Scholar PubMed

98Thornton, J.R. and Losowsky, M.S. (1988) Opioid peptides and primary biliary cirrhosis. Br Med J 297, 1501-1504CrossRef Google Scholar PubMed

99Bergasa, N.V. et al. (1995) Cholestasis is associated with preproenkephalin mRNA expression in the adult rat liver. Am J Physiol 68, G346-354Google Scholar

100Swain, M.G. et al. (1992) Endogenous opioids accumulate in plasma in a rat model of acute cholestasis. Gastroenterology 103, 630-635CrossRef Google Scholar

101Marzioni, M. et al. (2007) Endogenous opioid peptides and chronic liver disease: from bedside to bench. J Hepatol 46, 583-586CrossRef Google Scholar PubMed

102De Minicis, S. et al. (2008) Role Of Endogenous Opioids In Modulating HSC Activity In Vitro And Liver Fibrosis In Vivo. Gut 57, 352-364CrossRef Google Scholar PubMed

103Centonze, D. et al. (2007) The endocannabinoid system in targeting inflammatory neurodegenerative diseases. Trends Pharmacol Sci 28, 180-187CrossRef Google Scholar PubMed

104Woods, S.C. (2008) Role of the endocannabinoid system in regulating cardiovascular and metabolic risk factors. Am J Med (Suppl 1) 120, S19-S25CrossRef Google Scholar

105Siegmund, S.V. et al. (2005) Anandamide induces necrosis in primary hepatic stellate cells. Hepatology 41, 1085-1095CrossRef Google Scholar PubMed

106Julien, B. et al. (2005) Antifibrogenic role of the cannabinoid receptor CB2 in the liver. Gastroenterology 128, 742-755CrossRef Google Scholar PubMed

107Siegmund, S.V. et al. (2007) The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species. FASEB J 21, 2798-2806CrossRef Google Scholar PubMed

108Hézode, C. et al. (2005) Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C. Hepatology 42, 63-71CrossRef Google Scholar PubMed

109Teixeira-Clerc, F. et al. (2006) CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. Nat Med 12, 671-676CrossRef Google Scholar PubMed

110Kunos, G. et al. (2006) Cannabinoids hurt, heal in cirrhosis. Nat Med 12, 608-610CrossRef Google Scholar PubMed

111Marzioni, M. et al. (2006) Endogenous opioids modulate the growth of the biliary tree in the course of cholestasis. Gastroenterology 130, 1831-1847CrossRef Google Scholar PubMed

112Oo, Y.H. and Neuberger, J. (2004) Options for treatment of primary biliary cirrhosis. Drugs 64, 2261-2271CrossRef Google Scholar PubMed

113Johnson, B.A. (2008) Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings. Biochem Pharmacol 75, 34-56CrossRef Google Scholar PubMed

114Lillo, J.L. (2007) The endocannabinoid system as a novel approach for managing obesity. J Am Osteopath Assoc (Suppl 2) 107, S12-S20Google Scholar PubMed

115Iwakiri, Y. and Groszmann, R.J.The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology (Suppl 1) 43, S121-S131CrossRef Google Scholar

116Gary-Bobo, M. et al. (2007) Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats. Hepatology 46, 122-129CrossRef Google Scholar PubMed

117Nocito, A. et al. (2007) Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis. Gastroenterology 133, 608-618CrossRef Google Scholar

Article contents

Wound healing and local neuroendocrine regulation in the injured liver

Abstract

Access options

References

References

Further reading, resources and contacts

This article has been cited by the following publications. This list is generated based on data provided by Crossref.

Article contents

Wound healing and local neuroendocrine regulation in the injured liver

Abstract

Access options

References

References

Further reading, resources and contacts

Save article to Kindle

Save article to Dropbox

Save article to Google Drive

Reply to: Submit a response

Your details

You have entered the maximum number of contributors

Conflicting interests